Recently, a research team led by Prof. Wang Hongzhi from the Hefei Institutes of Physical Science, Chinese Academy of ...

Deepfake X-rays created by AI are now convincing enough to fool both doctors and AI models. In tests, radiologists had ...

Prostate cancer affects one in five Australian men, making it the most common cancer in the country. Now, researchers at the ...

Join us at HIMSS26, the premier event that brings together healthcare professionals, technology partners, policymakers and thought leaders for four days of learning, collaboration and inspiration.

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...

AURORA, Colorado — Researchers at the CU Anschutz Cancer Center have launched a clinical trial funded by the National Cancer Institute that will evaluate blood tests that could detect a number of ...

This repository provides code and workflows to test several state-of-the-art vehicle detection deep learning algorithms —including YOLOX, SalsaNext, RandLA-Net, and VoxelRCNN— on a Flash Lidar dataset ...

People who have received a cancer diagnosis are living longer than ever, according to a new report from the American Cancer Society (ACS). Decades of cancer research have led to more effective ...

A tool for spotting pancreatic cancer in routine CT scans has had promising results, one example of how China is racing to apply A.I. to medicine’s tough problems. Self-service kiosks at the ...

If everyone eligible had a lung cancer screening, 62,000 lives would be saved over five years, a new study shows. By Simar Bajaj Tens of thousands of lives could be saved if more people got screened ...

Skin cancer is highly treatable, if it’s caught early. But spotting it can be tricky. How it shows up on the skin can look different depending on skin tone. And for people with darker skin, that ...

Lung cancer symptoms are often non-specific, leading to late detection and misattribution to less severe conditions. The GO2 for Lung Cancer provides resources, policy advocacy, and access to clinical ...